APA (7th ed.) Citation

H, J., H, H., & X, P. (2026). PRMT3 in cancer: Arginine methylation as a driver of tumor metabolism, immune evasion, and therapeutic resistance. Frontiers in immunology, 17, 1828765. https://doi.org/10.3389/fimmu.2026.1828765

Chicago Style (17th ed.) Citation

H, Jin, Huang H, and Pan X. "PRMT3 in Cancer: Arginine Methylation as a Driver of Tumor Metabolism, Immune Evasion, and Therapeutic Resistance." Frontiers in Immunology 17 (2026): 1828765. https://doi.org/10.3389/fimmu.2026.1828765.

MLA (9th ed.) Citation

H, Jin, et al. "PRMT3 in Cancer: Arginine Methylation as a Driver of Tumor Metabolism, Immune Evasion, and Therapeutic Resistance." Frontiers in Immunology, vol. 17, 2026, p. 1828765, https://doi.org/10.3389/fimmu.2026.1828765.